Filing Details

Accession Number:
0001178913-10-002410
Form Type:
5
Zero Holdings:
No
Publication Time:
2010-09-13 10:02:50
Reporting Period:
2009-12-31
Filing Date:
2010-09-13
Accepted Time:
2010-09-13 10:02:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1451980 Biocancell Therapeutics Inc. BICL Pharmaceutical Preparations (2834) 204630076
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
919593 Idb Holding Corp Ltd 3 Azrieli Center, Triangle Tower
44Th Floor
Tel Aviv L3 67023
No No Yes No
919594 Idb Development Corp Ltd 3 Azrieli Center, Triangle Tower
44Th Floor
Tel Aviv L3 67023
No No Yes No
1051856 Ltd Investments & Industries Clal 3 Azrieli Center, Triangle Tower
45Th Floor
Tel Aviv L3 67023
No No Yes No
1355204 Nochi Dankner 3 Azrieli Center
44Th Floor
Tel Aviv L3 67023
No No Yes No
1355205 Shelly Bergman 9 Hamishmar Ha'Ezrachi Street
Afeka
Tel Aviv L3 69697
No No Yes No
1355206 Ruth Manor 26 Hagderot Street
Savyon L3 56526
No No Yes No
1355207 Avraham Livnat Taavura Junction 1
Ramle L3 72102
No No Yes No
1468950 Ltd. Industries Biotechnology Clal Triangular Tower, 45 Floor
3 Azrieli Center
Tel Aviv L3 67023
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2009-10-13 5,500 $0.85 3,842,673 No 4 S Direct
Common Stock Disposition 2009-10-15 4,228 $0.88 3,838,445 No 4 S Direct
Common Stock Disposition 2009-10-15 4,000 $0.82 3,834,445 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction was executed in New Israeli Shekel ("NIS"). The price indicated in the table is based on the exchange rate of NIS and US dollar last reported by the Bank of Israel (NIS 3.782 for US$1).